Adjuvant psychological therapy in long-term endocrine conditions.

Clin Endocrinol (Oxf)

Department of Psychology, Research Centre for Behaviour Change, Bournemouth University, Bournemouth, UK.

Published: June 2017

Consideration of psychological distress in long-term endocrine conditions is of vital importance given the prevalence of anxiety and depression in such disorders. Poor mental health can lead to compromised self-care, higher utilization of health services, lower rates of adherence, reduced quality of life and ultimately poorer outcomes. Adjuvant psychological therapy offers an effective resource to reduce distress in endocrine conditions. While the vast majority of work in this area has focused on psychological screening and intervention in diabetes, identification and recognition of psychological distress are equally important in other endocrinological conditions, with supportive evidence in polycystic ovary syndrome and Addison's disease. Referral pathways and recommendations set out by UK guidelines and the Department of Health mandate requires greater attention across a wider range of long-term endocrine conditions to facilitate improved quality of life and health outcome.

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.13341DOI Listing

Publication Analysis

Top Keywords

endocrine conditions
16
long-term endocrine
12
adjuvant psychological
8
psychological therapy
8
psychological distress
8
quality life
8
conditions
5
therapy long-term
4
endocrine
4
conditions consideration
4

Similar Publications

Unveiling the endocrine connections of NAFLD: evidence from a comprehensive mendelian randomization study.

Biomed Eng Lett

January 2025

Department of Gastroenterology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006 China.

Background: NAFLD is gaining recognition as a complex, multifactorial condition with suspected associations with endocrine disorders. This investigation employed MR analysis to explore the potential causality linking NAFLD to a spectrum of endocrine diseases, encompassing T1D, T2D, obesity, graves' disease, and acromegaly.

Methods: Our methodology leveraged a stringent IV selection process, adhering to the STROBE-MR guidelines.

View Article and Find Full Text PDF

HnRNPM modulates alternative splicing in germ cells by recruiting PTBP1.

Reprod Biol Endocrinol

January 2025

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Background: Heterogeneous nuclear ribonucleoprotein M (HnRNPM) is a key splicing factor involved in various biological processes, including the epithelial‒mesenchymal transition and cancer development. Alternative splicing is widely involved in the process of spermatogenesis. However, the function of hnRNPM as a splicing factor during spermatogenesis remains unknown.

View Article and Find Full Text PDF

Adverse early-life experiences alter the regulation of major stress systems such as the hypothalamic-pituitary-adrenal (HPA) axis. Low early-life maternal care (MC) has repeatedly been related to blunted cortisol stress responses. Likewise, an acutely increased awareness of mortality (mortality salience [MS]) also has been shown to blunt cortisol responses.

View Article and Find Full Text PDF

Unveiling FOXO3's metabolic contribution to menopause and Alzheimer's disease.

Exp Gerontol

January 2025

Department of Biological Sciences, University of Limerick, Limerick V94 T9PX, Ireland. Electronic address:

The increasing prevalence of Alzheimer's disease (AD) calls for a comprehensive exploration of its complex etiology, with a focus on sex-specific vulnerability, particularly the heightened susceptibility observed in postmenopausal women. Neurometabolic alterations during the endocrine transition emerge as early indicators of AD pathology, including reduced glucose metabolism and increased amyloid-beta (Aβ) deposition. The fluctuating endocrine environment, marked by declining estradiol levels and reduced estrogen receptor beta (ERβ) activity, further exacerbates this process.

View Article and Find Full Text PDF

Rare endocrine diseases are complex conditions that require lifelong specialized care due to their chronic nature and associated long-term complications. In Korea, a lack of nationwide data on clinical practice and outcomes has limited progress in patient care. Therefore, the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) study was initiated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!